This is a preview of updates coming to the Technical Bulletin's website in April 2026. Return to current site.
Read more about the modernization release schedule in this announcement.
Comment via the yellow feedback button in the lower right hand corner of the page. Contact the NLM Help Desk with any questions or concerns.
This is archived content.
Links may have become inactive over time. Visit Archive-It to find the original published layout.
RxNorm August 2022 Full Monthly Release
RxNorm August 2022 Full Monthly Release. NLM Tech Bull. 2022 Jul-Aug;(447):b6.
August 01, 2022 [posted]
The RxNorm August 2022 monthly release became available on Monday, August 1, 2022 and includes a new Novavax COVID-19 vaccine concept.
RXNORM DATA CHANGES
Novavax COVID-19 Vaccine Added
The U.S. Food and Drug Administration recently issued an emergency use authorization (EUA) for the Novavax COVID-19 Vaccine, Adjuvanted for the prevention of COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 18 years of age and older.
Here is the new Novavax COVID-19 vaccine concept in the August 2022 RxNorm release:
| RXCUI | Term Type (TTY) | STRING |
| 2606078 | SCD | SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2373 0.01 MG/ML Injectable Suspension |